Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM) on Monotherapy
Type 2 Diabetes Mellitus
About this trial
This is an interventional supportive care trial for Type 2 Diabetes Mellitus focused on measuring Remote Blood Glucose Monitoring System, Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria:
- Type 2 diabetes patients treated with only 1 oral anti-diabetic medication
- A1C 7-11%
- >25 years of age
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be randomized
- Trained in self blood glucose monitoring
- Internet Access
Exclusion Criteria:
- Patients who do not meet the inclusion criteria or are not willing to participate will not be included in the study.
- In addition patients with the potential to become pregnant or patients using medications known to influence control of diabetes (eg steroids systemic or inhaled) are excluded from the study.
Sites / Locations
- St. Paul's Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Internet Intervention
Standard Care
The subjects enrolled in the Internet Therapeutic Intervention arm receive standard care by testing their blood glucose at least 3 times daily and visit the endocrinologist every 3 months; however, they are also asked to upload their blood glucose readings online every 2 weeks for the health practitioner to view and comment upon.
This arm will receive standard care which includes self-blood glucose monitoring at least 3 times daily and visit to the endocrinologist at least once every 3 months.